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Abstract
Purpose 18F-Fluorodeoxyglucose positron emission tomography (18F-FDGPET/CT) is frequently used to diagnose fracture-related
infections (FRIs), but its diagnostic performance in this field is still unknown. The aims of this study were: (1) to assess the
diagnostic performance of qualitative assessment of 18F-FDG PET/CT scans in diagnosing FRI, (2) to establish the diagnostic
performance of standardized uptake values (SUVs) extracted from 18F-FDG PET/CT scans and to determine their associated
optimal cut-off values, and (3) to identify variables that predict a false-positive (FP) or false-negative (FN) 18F-FDG PET/CT result.
Methods This retrospective cohort study included all patients with suspected FRI undergoing 18F-FDG PET/CT between 2011 and
2017 in two level-1 trauma centres. Two nuclear medicine physicians independently reassessed all 18F-FDG PET/CT scans. The
reference standard consisted of the result of at least two deep, representative microbiological cultures or the presence/absence of
clinical confirmatory signs of FRI (AO/EBJIS consensus definition) during a follow-up of at least 6 months. Diagnostic perfor-
mance in terms of sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) was calculated.
Additionally, SUVs were measured on 18F-FDG PET/CT scans. Volumes of interest were drawn around the suspected and corre-
sponding contralateral areas to obtain absolute values and ratios between suspected and contralateral areas. A multivariable logistic
regression analysis was also performed to identify the most important predictor(s) of FP or FN 18F-FDG PET/CT results.
Results The study included 156 18F-FDG PET/CTscans in 135 patients. Qualitative assessment of 18F-FDG PET/CTscans showed
a sensitivity of 0.89, specificity of 0.80, PPVof 0.74, NPVof 0.91 and diagnostic accuracy of 0.83. SUVs on their own resulted in
lower diagnostic performance, but combining them with qualitative assessments yielded an AUC of 0.89 compared to an AUC of
0.84 when considering only the qualitative assessment results (p = 0.007). 18F-FDG PET/CT performed <1month after surgery was
found to be the independent variable with the highest predictive value for a false test result, with an absolute risk of 46% (95% CI
27–66%), compared with 7% (95% CI 4–12%) in patients with 18F-FDG PET/CT performed 1–6 months after surgery.
Conclusion Qualitative assessment of 18F-FDG PET/CTscans had a diagnostic accuracy of 0.83 and an excellent NPVof 0.91 in
diagnosing FRI. Adding SUVmeasurements to qualitative assessment provided additional accuracy in comparison to qualitative
assessment alone. An interval between surgery and 18F-FDG PET/CT of <1 month was associated with a sharp increase in false
test results.
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Introduction
Fracture-related infection (FRI) is a serious complica-
tion following trauma surgery and can lead to increased
morbidity and high medical costs [1, 2]. Clinical symp-
toms are not always evident, therefore diagnosing FRI
can be challenging. This problem was worsened by the
fact that, until recently, there was no uniform definition
o f FR I [ 3 ] . R e c e n t l y , t h e AO F o u n d a t i o n
(Arbeitsgemeinschaft für Osteosynthesefragen) and the
European Bone and Joint Infection Society (EBJIS)
published a consensus definition comprising confirma-
tory and suggestive criteria for diagnosing FRI [4].
Medical imaging is considered to be only an adjunct
to the diagnosis of FRI (i.e. a suggestive criterion).
The reason for this is that the evidence for its accuracy
in diagnosing FRI is limited. Moreover, such evidence
as is available was obtained mainly from studies inves-
tigating other causes of bone infection such as diabetic
foot infection, periprosthetic joint infection (PJI) and
haematogenous osteomyelitis [5]. Most previous studies
on diagnostic imaging of FRI have been hampered by
small patient cohorts, unclear reference standards and
heterogeneous patient populations [5, 6]. Recently, our
group found that white blood cell (WBC) scintigraphy
has a high accuracy (0.92) when diagnosing FRI [7]. To
compare imaging modalities, we used the same study
design to evaluate the diagnostic performance of 18F-
fluorodeoxyglucose positron emission tomography/
computed tomography (18F-FDG PET/CT).
The aims of the current study were:
1. To establish the performance of qualitative assessment of
18F-FDG PET/CT scans in diagnosing FRI
2) To establish the performance of standardized uptake
values (SUVs) from 18F-FDG PET/CT in diagnosing
FRI and to determine their optimal associated cut-off
values
3) To determine which variables are independent predictors
of a false positive (FP) or false negative (FN) 18F-FDG
PET/CT test result in patients with suspected FRI
Materials and methods
Ethical approval
Due to the observational nature of this study the need for
informed consent was waived by the Medical Ethics Review
Committee (METC) of the University Medical Center Utrecht
(METC 17-475).
Study design and eligibility criteria
This was a two-centre, retrospective cohort study that includ-
ed patients from two large level-1 trauma centres in
The Netherlands: the University Medical Center Utrecht and
the University Medical Center Groningen. All consecutive
patients undergoing 18F-FDG PET/CT for diagnosing (or ex-
cluding) FRI between January 2011 and November 2017 were
eligible for inclusion. FRI was considered as either an infec-
tion following an open fracture (irrespective of type of treat-
ment), an infection following fracture surgery, or an infection
following instrumented fusion for spinal fractures. Skeletally
immature patients (<16 years old) and patients undergoing
18F-FDGPET/CT for reasons other than diagnosing FRI (such
as PJI, nontraumatic osteosyntheses or haematogenous osteo-
myelitis) were excluded. Patients in whom the reference test
did not meet the criteria for validity, as described in the section
Reference test, were also excluded.
Index test
The index test was the 18F-FDG PET/CT scan. Scanning pro-
tocols were similar in both centres. Scans were acquired ap-
proximately 60 min after intravenous administration of 2–
3 MBq/kg 18F-FDG according to existing European
Association of Nuclear Medicine (EANM) guidelines for
18F imaging [8]. Scans were acquired on either a Biograph
mCT 64-slice or a Biograph mCT 40-slice PET/CT system
(Siemens, Knoxville, TN, USA). No metal artefact reduction
algorithm was used in either centre.
After anonymization, the scans were independently
reassessed by two experienced nuclear medicine physicians
(M.G.G.H. and A.W.J.M.G.). Both the attenuation-corrected
images and the images without attenuation correction were
reviewed. Both nuclear medicine physicians were blinded to
the reference test result. Nuclear imaging signs were docu-
mented for each of the scans on a case report form (CRF).
These signs included uptake location, uptake pattern (multifo-
cal, heterogeneous, diffuse homogeneous), uptake grade (0:
no uptake, 1: higher uptake in the side with suspected infec-
tion than in the contralateral side, 2:much higher uptake in the
side with suspected infection than in the contralateral side),
involvement of osteosynthesis material, and soft-tissue and
bone involvement. Disagreements were resolved through dis-
cussion until consensus was reached. A clinical case example
of the use of 18F-FDG PET/CT for diagnosing FRI is provided
in Fig. 1.
For semiquantitative analysis, SUVs were also measured
on 18F-FDG-PET/CT scans reconstructed according to
EANM EARL protocols. SUVs correspond to the extent of
18F-FDG uptake and consequently reflect cellular glucose me-
tabolism. Because glucose metabolism is increased in infected
tissues, higher SUVs correspond to a greater risk of FRI than
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lower SUVs [9]. SUVs were determined by drawing a spher-
ical volume of interest (VOI) on both the target area with
suspected infection and a corresponding anatomical reference
area on the contralateral side. Additionally, a VOI was drawn
on nearby muscle for background comparison. For all VOIs,
both SUVmax (single-pixel value) and SUVpeak (average value
in a high-uptake part of the VOI) were calculated. For both
SUVmax and SUVpeak, the ratios between the suspected infected
side and the contralateral side were also calculated (SUVmaxratio
and SUVpeakratio). To correct for background
18F-FDG uptake,
ratios between the SUVs of the suspected infected site and the
SUVs of nearby muscles (SUVmaxmusc l e r a t i o and
SUVpeakmuscleratio) were calculated. These data were reported
in a separate CRF as continuous measurements. All SUV mea-
surements were corrected for body weight and blood glucose
level and were performed with syngo.via software (Siemens
Healthineers, Forchheim, Germany).
Reference test
The final diagnosis of FRI (reference test) was based on the
outcome of medical microbiological (MMB) culture results in
patients with surgical intervention, or – if unavailable – on
clinical follow-up of at least 6 months. Because this study
involved the retrospective analysis of culture results obtained
in an era when no uniform culturing protocol existed, strict
criteria for judging the validity of the reference test were ap-
plied. All MMB results were judged by an experienced trauma
surgeon on their ability to correctly detect FRI. The microbi-
ological results from swabs and cultures of fistulas were
disregarded due to relatively low accuracy [10–12]. The
MMB results were only considered representative if cultures
of at least two surgically obtained deep-tissue samples from
the site of suspected infection were available. A positive FRI
result was defined as at least two positive representativeMMB
Fig. 1 A 59-year-old man sustained a right-sided Gustilo grade IIIB open
crural fracture (a) which was treated with intramedullary nailing and a
fasciotomy (b). After several soft-tissue debridement procedures, the re-
maining soft tissue defect was eventually closed with a free
musculocutaneous flap. After 20 months, there was a non-union with
Bautodynamization^ of the intramedullary nail, demonstrated by broken
interlocking screws (c). The 18F-FDG PET image (d) shows increased
uptake around the fracture site in the tibial shaft and around the proximal
and distal screws. The hybrid 18F-FDG PET/CT images (e axial, f
coronal, g sagittal) localize the suspected fracture-related infection
(FRI) not only to the fracture site but also to the surrounding bone of
the tibia around the fracture site which corresponds to the unstable scar
overlapping the area of the non-union (h). The intramedullary nail was
removed, the tibia was reamed, the fracture site was debrided and an in-
house, custom-made antibiotic nail was inserted (I). FRI was confirmed
by microbiological cultures and the patient was subsequently treated with
antibiotics. One year after exchange nailing, fracture healing was success-
ful (j)
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cultures with the same microorganism according to the micro-
biological criteria outlined in the AO/EBJIS consensus defi-
nition [4]. FRI during clinical follow-up was defined accord-
ing to the clinical confirmatory criteria of the AO/EBJIS con-
sensus definition as any wound breakdown, purulent drainage
or the presence or development of a sinus tract (communicat-
ing with the implant material) [4]. If culture results were neg-
ative but confirmatory criteria for FRI were met (e.g. pus,
fistula) peroperatively when cultures were taken, FRI was
deemed to be present (and the culture result was considered
to be erroneous). Culture-negative FRIs are known to be
caused by bacteria with low virulence such as coagulase-
negative Staphylococcus species [13].
Statistical analyses
To assess the diagnostic performance of the 18F-FDG PET/CT
scan, the number of true-positive (TP), FP, true-negative (TN)
and FN test results were obtained. From this, sensitivity, spec-
ificity, positive predictive values (PPV), negative predictive
values (NPV), positive and negative likelihood ratios and di-
agnostic odds ratios with 95% confidence intervals (CI) were
calculated. A sensitivity analysis was performed including
only the first scan in each patient to determine whether selec-
tion bias of patients undergoing multiple scans may have con-
tributed to differences in diagnostic parameters.
All SUVs were compared between groups using Student’s t
test (if normally distributed) or the Mann-Whitney U test (if
not normally distributed). Normality of the data was deter-
mined by visual inspection of normality plots. The sensitivity
and specificity of the separate SUV measurements were plot-
ted as receiver operating characteristic (ROC) curves and for
each curve, the area under the curve (AUC) was calculated.
The Q-point on each curve (i.e. the point at which sensitivity
and specificity were maximized) was determined and the as-
sociated cut-off value was extracted. In addition, an ROC
curve was plotted combining the diagnostic performance of
SUV measurements with the performance of qualitative as-
sessment. The difference between the ROC curve from the
combined analysis and the ROC curve with only the qualita-
tive assessment was analysed using the test described by
DeLong et al. [14]. To ensure that this test was appropriately
applied in this situation of nested models, we investigated
whether the added variable Bcombined SUV measurements^
in the combined model was independently associated with the
outcome [15].
Consequently, a backward stepwise multivariable logistic
regression analysis was performed to determine which vari-
ables were independent predictors of a false (i.e. FP or FN) test
result. Removal testing was performed with the probabilities
of the likelihood ratio statistic based on the maximum partial
likelihood estimates. Multiple variables suggested in the liter-
ature to influence 18F-FDG PET/CT accuracy were included
in the model [16]. The variables entered were: interval be-
tween the last operative procedure (or date of trauma if no
operation was performed) and the 18F-FDG PET/CT scan (or-
dinal; <1 month, between 1 and 6 months and >6 months),
body mass index (continuous), presence of diabetes mellitus
(dichotomous), smoking history (dichotomous), nonsteroidal
antiinflammatory drug (NSAID) use at the time of 18F-FDG
PET/CT (dichotomous) and antibiotic use at the time of 18F-
FDGPET/CT (dichotomous). Using the final model, the prob-
abilities of false test results were obtained (with 95% CIs) for
the different variables. Additionally, the diagnostic perfor-
mance of qualitative assessment was calculated excluding
scans with a high risk of a false test result. All statistical anal-
yses were performed with SPSS Statistics version 25.0 (IBM
Corp., Armonk, NY).
Results
In the study period, 154 patients underwent 176 18F-FDG PET/
CT scans for suspected FRI. The reference test was not per-
formed in 18 patients and these patients were excluded. Two
18F-FDGPET/CTscans in skeletally immature patientswere also
excluded. A total of 135 patients who underwent 156 18F-FDG
PET/CT scans were ultimately included. The patient characteris-
tics are summarized in Table 1. The fracture specifics are pre-
sented in Table 2, and the types of index operation in Table 3.
For 67 18F-FDGPET/CTscans (43%), a representativeMMB
culture result was available. These scans were obtained from
patients with a median clinical follow-up of 13 months (IQR
20months), 33 of these scans (49%) were obtained from patients
that had a MMB culture-confirmed FRI. Staphylococcus species
were most commonly cultured (Table 4). In 11 patients, culture
results were negative but there were peroperative confirmatory
signs of FRI, including purulent drainage, wound breakdown or
a fistula communicating with implant material. These patients
were scored as positive for FRI.
For 89 18F-FDG PET/CT scans (57%), representative
MMB culture results were not available. These scans were
obtained from patients with a median clinical follow-up of
16 months (IQR 23 months), 18 of these scans were obtained
from patients that showed clinical confirmatory signs of FRI,
the remainder of these patients had an uneventful clinical fol-
low-up. The 71 remaining patients had an uneventful clinical
follow-up. In total, 62 patients were diagnosed with FRI. In 55
of these 62 patients, 18F-FDG PET/CT was positive for FRI
(TP). In 75 of 94 patients negative for FRI, 18F-FDG PET/CT
correctly ruled out an FRI (TN). The 18F-FDG PET/CT result
was FP in 19 patients and FN in 7 patients. Thus, 18F-FDG
PET/CT showed a diagnostic sensitivity of 0.89 (95% CI
0.78–0.95), specificity of 0.80 (95% CI 0.70–0.87), PPV of
0.74 (95% CI 0.66–0.81), NPVof 0.91 (95% CI 0.84–0.96),
positive likelihood ratio of 4.39 (95% CI 2.91–6.62), negative
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likelihood ratio of 0.14 (95% CI 0.07–0.29), and diagnostic
odds ratio of 31.0 (95% CI 12.2–78.9). The accuracy of 18F-
FDG PET/CT for diagnosing FRI was 0.83 (95% CI 0.77–
0.89). The sensitivity analysis including only the first 18F-
FDG PET/CT scan in each patient (N = 135) resulted in sim-
ilar diagnostic parameters: sensitivity 0.91 (95% CI 0.80–
0.97), specificity 0.81 (95% CI 0.70–0.89), PPV 0.77 (95%
CI 0.68–0.84), NPV 0.93 (95% CI 0.84–0.97) and diagnostic
accuracy 0.85 (95% CI 0.78–0.91).
Semiquantitative measurements
Semiquantitative SUV measurements are presented in
Table 5. Patients with FRI had a median SUVmax of 5.9
(IQR 3.5) and median SUVpeak of 4.7 (IQR 2.4) in the area
with suspected infection. Patients without FRI had a median
SUVmax of 3.2 (IQR 2.5) and a median SUVpeak of 2.6 (IQR
1.9) in the area initially suspected of infection. The differ
ences in both SUVmax and SUVpeak between the groups were
significant (both p < 0.001). In patients with FRI, the SUV
ratios for the area with suspected infection in relation to the
contralateral area were 3.0 (IQR 2.1) for SUVmax and 2.9
(IQR 2.0) for SUVpeak. In patients without FRI, the ratios were
1.9 (IQR 1.4) and 1.8 (IQR 1.4), respectively. Both ratios were
significantly different between patients with and without FRI
(p < 0.001). In patients with FRI, the SUV ratios for the area
with suspected infection in relation to nearby muscle were 6.4
(IQR 4.9) for SUVmax and 5.5 (IQR 3.6) for SUVpeak. In
Table 2 Fracture characteristics
Classification Number (%) of scans
AO classification
1: Humerus fractures 5 (3.2)
13: Distal 1 (0.6)
15: Clavicle 4 (2.6)
2: Radius/ulna fractures 8 (5.1)
21: Proximal 3 (1.9)
22: Diaphyseal 3 (1.9)
23: Distal 2 (1.3)
3: Femur fractures 25 (16.0)
31: Proximal 1 (0.6)
32: Diaphyseal 18 (11.5)
33: Distal 6 (3.8)
4: Tibia/fibula fractures 88 (56.4)
41: Proximal 12 (7.7)
42: Diaphyseal 48 (30.8)
43: Distal 16 (10.3)
44: Malleolar 12 (7.7)
5: Spine fractures 14 (9.0)
A: Compression injury 9 (5.8)
B: Distraction injury 1 (0.6)
C: Dislocation injury 3 (1.9)
Unknown 1 (0.6)
6: Pelvis/sacrum fractures 5 (3.2)
8: Foot fractures 11 (7.1)
81: Talus 3 (1.9)
82: Calcaneus 6 (3.8)
83: Navicular 1 (0.6)
Unknown 1 (0.6)
Gustilo-Anderson classification
Closed fractures 68 (43.6)
Open fractures 76 (48.7)
Type I 13 (8.3)
Type II 11 (7.1)
Type IIIA 20 (12.8)
Type IIIB 6 (3.8)
Type IIIC 3 (1.9)
Unknown 23 (14.7)
Unknown 12 (7.7)
AO Arbeitsgemeinschaft für Osteosynthesefragen
Table 1 Baseline characteristics
Characteristic Value
Age (years), mean (range) 46.7 (16–76)
Sex (male), n (%) 112 (71.8)
Body mass index (kg/m2), mean (range) 27.1 (15.3–48.1)










Comorbidities/risk factors at time of 18F-FDG PET/CT, n (%)
Diabetes mellitus 16 (10.3)




Tobacco use 63 (40.4)
Alcohol abuse 11 (7.1)
Drug abuse 9 (5.8)
NSAID use 34 (21.8)
Corticosteroid use 3 (1.9)
Antibiotic use 35 (22.4)
ASA American Society of Anesthesiologists, NSAID nonsteroidal
antiinflammatory drug
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patients without FRI, the ratios were 3.5 (IQR 3.0) and 3.3
(IQR 2.9), respectively. These ratios were also significantly
different between patients with and without FRI (p < 0.001).
ROC curves for the semiquantitative SUV data are shown
in Fig. 2. The areas under the curve were 0.80 (95% CI 0.73–
0.88) for SUVmax, 0.73 (95% CI 0.64–0.81) for SUVmaxratio
and 0.77 (95% CI 0.70–0.85) for SUVmaxmuscleratio. Optimal
sensitivity and specificity for SUVmax were 0.80 and 0.72 at a
cut-off value of 4.2. The PPVand NPV for SUVmax at this cut-
off value were 0.65 and 0.85, respectively. For SUVmaxratio,
sensitivity was 0.75 and specificity was 0.62 at a cut-off value
of 2.0, and for SUVmaxmuscleratio, sensitivity was 0.74 and
specificity was 0.68 at a cut-off value of 4.7. The diagnostic
parameters and associated cut-off values for SUVpeak were
similar to those for SUVmax and are also shown in Fig. 2.
Combining the SUVmeasurement data with the qualitative
assessment of 18F-FDG PET/CT scans in a separate ROC
curve yielded an AUC of 0.89 (95% CI 0.84–0.95) and a
diagnostic accuracy of 0.86 (sensitivity 0.85, specificity
0.87, PPV 0.81, NPV 0.90), in contrast to an AUC of 0.84
(95% CI 0.78–0.91) and a diagnostic accuracy of 0.83 for the
qualitative assessment on its own. The added explanatory var-
iable Bcombined SUV measurements^ was independently as-
sociated with the presence/absence of FRI and comparison of
the ROC curves was deemed appropriate. The AUC of the
combined assessment was 0.05 (95% CI 0.01–0.09) greater
than the AUC of the qualitative assessment alone (p = 0.007).
Characteristics of patients
with false-negative/false-positive results
Seven patients were included with a FN test result. Two pa-
tients had positive intraoperative cultures, while five patients
showed confirmatory signs peroperatively or during the 6-
month follow-up. Two patients had (low-grade) infection of
a non-union (both ankle fractures). Another patient (with two
scans) showed peroperative signs of FRI in the tibia (infected
tissue and pus) despite microbiological cultures remaining
negative. There were 19 patients with a FP test result. These
included two patients with a lower arm fracture, two with a
femoral fracture, two with a tibial plateau fracture, seven with
a lower leg fracture, two with an ankle fracture, two with a
talar fracture and two with a spinal fracture. Eight patients had
a negative intraoperative culture, 11 had no cultures taken but
showed no signs of FRI during the 6-month follow-up. Five
patients (26%) with a FP result underwent surgery during the
week before the 18F-FDG PET/CT scan (one with a tibial
fracture, one with a talar fracture, one with an ankle fracture,
and two with a tibial plateau fracture). These scans were per-
formed to determine if the FRI had receded or was still ad-
vancing in patients who underwent surgery for suspected FRI
shortly before the scan.
Predictors of a false test result
The most important predictor of a false test result was an
interval of <1 month between the last operative procedure
and the 18F-FDG PET/CT scan (B = 2.461, intercept
Table 4 Microbiological findings in 33 patients with MMB culture-
confirmed FRI in relation to the 18F-FDG PET/CT result


























Table 3 Index procedures




Intramedullary nail 35 (22.4)
Arthrodesis (including spinal fusion) 14 (9.0)
Amputation 1 (0.6)




Intramedullary nail 5 (3.2)
Conservative 2 (1.3)
Unknown 6 (3.8)
Closed reduction/conservative 5 (3.2)
Unknown 1 (0.6)
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−2.615). The associated absolute predicted risk of a false re-
sult with this variable was 46% (95% CI 27–66%) compared
with an absolute predicted risk of the reference group (with an
interval of 1–6 months) of 7% (95% CI 4–12%). In patients
with an interval of >6 months, the absolute risk was 17%
(95% CI 10–29%). The test result was erroneous in 6 of 14
patients (42.9%) undergoing 18F-FDG PET/CT within
1 month (FP in all six patients). The rate of erroneous test
results reduced to 8.9% (4 of 45 patients) in those with an
interval between 1 and 6 months, and showed a slight increase
to 16.8% (16 out of 95 patients) in those with an interval of
more than 6 months. Omitting the results from the early 18F-
FDG PET/CT scans (performed within 1 month of surgery)
led to an increase in diagnostic accuracy of the qualitative
assessment to 0.86 (95% CI 0.79–0.91) with a sensitivity
and specificity of 0.88 (95% CI 0.76–0.95) and 0.85 (95%
CI 0.76–0.92), respectively.
Discussion
The current study showed that qualitative assessment of
18FDG PET/CT scans has good performance in diagnosing
FRI with a diagnostic accuracy of 0.83 (95% CI 0.77–0.89)
and an AUC of 0.84 (95% CI 0.78–0.91). The NPV (0.91)
was notably higher than that of most other imagingmodalities,
and makes 18FDG PET/CTan excellent tool for use in patients
with chronic or low-grade infections [5]. Combining the re-
sults of qualitative assessment and SUV measurements result-
ed in an even higher diagnostic accuracy (0.86) and an AUC
of 0.89 (95%CI 0.84–0.95), which shows that including SUV
measurements increased diagnostic accuracy, although the in-
crease was relatively small.
The sensitivity and specificity rates found in this study are
in line with those found in other studies on the accuracy of
18F-FDG PET/CT in diagnosing FRI [5, 9]. However, this
study also included semiquantitative measurements and used
strict 18F-FDG PET/CT assessment and reference test criteria
(based on the recently released AO/EBJIS consensus defini-
tion of FRI) [4]. It also included the largest series to date of
patients with suspected FRI undergoing hybrid 18F-FDGPET/
CT imaging. One systematic review and meta-analysis inves-
tigating the accuracy of different imaging modalities for diag-
nosing chronic osteomyelitis showed higher diagnostic accu-
racy of 18F-FDG PET with a pooled sensitivity of 0.96 and a
specificity of 0.91 [6]. That study, however, included only
studies published before 2003 and investigated only 18F-
FDGPETwithout fusion CT images, which is now rarely used
Table 5 Semiquantitative SUV













18F-FDG dose (MBq) 193.0 (77.0) 199.0 (132.0) 192.0 (70.0) 0.287
Blood glucose
(mmol/l)
5.6 (1.0) 5.7 (0.9) 5.5 (1.1) 0.241
SUVmax
Infection location 4.2 (3.4) 5.9 (3.5) 3.2 (2.5) <0.001
Contralateral
location




2.1 (1.8) 3.0 (2.1) 1.9 (1.4) <0.001
Infection/Muscle 4.6 (3.9) 6.4 (4.9) 3.5 (3.0) <0.001
SUVpeak
Infection location 3.5 (2.7) 4.7 (2.4) 2.6 (1.9) <0.001
Contralateral
location




2.1 (1.8) 2.9 (2.0) 1.8 (1.4) <0.001
Infection/Muscle 4.1 (3.4) 5.5 (3.6) 3.3 (2.9) <0.001
Data are presented as medians (IQR)
FRI fracture-related infection
a SUV measurements could not be retrieved in one patient for technical reasons.
b Ratios were calculated by dividing the SUVof the suspected infected area by the SUVof the contralateral area/
nearby muscle; a value of >1 signifies higher uptake in the suspected infected area.
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following the advent of 18F-FDG PET/CT scanners. In addi-
tion, reference test criteria were unclear in some of the studies
reviewed and the studies included few patients and a relatively
large number of spinal 18F-FDGPET/CTscans. Amore recent
systematic review found that the sensitivities and specificities
of 18F-FDG-PET/CT in diagnosing FRI ranges between 0.86–
0.94 and 0.76–1.00, respectively [5]. These results, as well as
the methodology used (patient population and reference stan-
dard) are comparable to those used in our study.
There is only limited research on the accuracy of quantifica-
tion in diagnosing FRI. A recent study on the accuracy of SUV
measurements from 18F-FDGPET/CT for diagnosing FRI found
a sensitivity of 0.65 and specificity of 0.77 at a SUVmax cut-off
value of 4.0 [17]. These values are lower than those published
previously for qualitative assessment of 18F-FDG PET/CT scans
[5]. The reason for this could be that the previous SUVmeasure-
ment study used only 18F-FDG PET/CT to differentiate between
infected non-unions and aseptic non-unions. In both circum-
stances, increased bonemetabolismwill often be found, and thus
differences between 18F-FDG uptake will be limited. The cut-off
value of 4.0 used in the previous study is similar to the SUVmax
cut-off value found in the current study (4.2). Unfortunately, the
validity of the results is difficult to compare between our study
and the previous study, because it is unclear whether the
Fig. 2 Receiver operating characteristics (ROC) curves for the semiquan-
titative SUV measurements analysed separately and in combination with
the qualitative 18F-FDG PET/CT assessment data. The circles on the
curves represent the Q-points (i.e. the optimum between sensitivity and
specificity at a specific cut-off value). The cross represents the sensitivity
and specificity of the qualitative 18F-FDG PET/CTassessment. This point
is higher than any of the Q-points for the semiquantitative measurements
alone. The area under the curve for the combined qualitative and semi-
quantitative assessment (dotted line) is 0.89, higher than the areas under
the curve for the semiquantitative measurements analysed separately and
also higher than the AUC of the qualitative assessment alone. AUROC
area under the receiver operator characteristics curve, SN sensitivity, SP
specificity, PPV positive predictive value, NPV negative predictive value
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standardized EARL scanning protocols were used in the latter
[18]. Additionally, only semiquantitative measurements, and no
qualitative criteria (such as uptake pattern and grade) for diag-
nosing FRI were used. SUV measurements do not take into
account the activity pattern and uptake location, and can be pos-
itive as a consequence of both bone healing and/or non-union.
Therefore, using only semiquantitative data might lead to mis-
classification of some patients. This is supported by the results of
our study, in which the diagnostic accuracy of the qualitative
assessment by the nuclear medicine physicians was higher than
the accuracy when using SUVs alone. This phenomenon was
also seen in a large study of patients with FRI which demonstrat-
ed a diagnostic accuracy of 0.82 with qualitative assessment of
18F-FDG PET(/CT) scans and a lower accuracy with only semi-
quantitative measurements (SUVmax sensitivity 0.69, specificity
0.66 using a cut-off value of 3.9) [9]. Another study investigating
SUVs in histologically proven culture-positive and culture-
negative patients with FRI showed that SUVs in both groups
of patients were similar (SUVmax 3.73 in culture-positive pa-
tients, 2.81 in culture-negative patients) [19]. The findings of
these studies, as well as those of the current study, add to the
mounting evidence that semiquantitative measurements can be
used as additional diagnostic tools for diagnosing FRI.
WBC scintigraphy has been more thoroughly investigated as
an imaging modality for diagnosing FRI. Our previous study of
WBC scintigraphy found a diagnostic accuracy of 0.92, which is
higher than the diagnostic accuracy found in the current study for
18F-FDG PET/CT [7]. However, 18F-FDG PET/CT does have
several advantages over WBC scintigraphy. First, there is no
need for manipulation of leukocytes, which is a labourious and
expensive part of WBC scintigraphy [20]. Second, 18F-FDG
PET/CT can be performed much more quickly (1 h following
radionuclide injection) and takes only one scanning session, as
opposed toWBC scintigraphy, which takes at least two scans (4 h
and 20–24 h after radionuclide injection) on two consecutive days
[20]. Third,WBC scintigraphy has lower accuracy when used for
diagnosing infections in the axial skeleton due to physiological
uptake in the bone marrow, while 18F-FDG PET/CT does not
have this limitation [16]. 18F-FDG PET/CT has the disadvantage
that implants negatively affect diagnostic accuracy, although in
some studies, this effect has not been shown [5, 9].With the recent
onset of several techniques for metal artefact reduction in the
newest generation PET/CT camera systems, the diagnostic per-
formance of both qualitative assessment and quantification in
patients with an implant and suspected FRI can probably be im-
proved further. Ultimately, both imaging modalities have their
specific advantages and limitations and although 18F-FDG PET/
CT has lower accuracy thanWBC scintigraphy, its advantages in
terms of logistics and patient comfort make it a good alternative to
WBC scintigraphy as the first nuclear imaging modality to per-
form when diagnosing FRI. Thus, both modalities can be used to
diagnose FRI depending on physician/hospital preference, finan-
cial considerations, and/or experience with either technique.
We found that performing the 18F-FDG PET/CT scan
<1 month following surgery was correlated with a FP 18F-FDG
PET/CT result. It is known that operative procedures cause tissue
damage and inflammation/regeneration, and affected tissue
shows increased uptake of 18F-FDG, especially when the interval
between the 18F-FDG PET/CT and surgery is short [16]. Five of
the FP 18F-FDGPET/CTscans were performedwithin a week of
an operative procedure. Both nuclear medicine physicians
reassessing these scans for this study agreed that in some of these
scans, inflammation due to surgery was indistinguishable from
FRI.We conclude that 18F-FDG PET/CTshould therefore not be
performed as a diagnostic tool within a month of surgery. If (per
protocol) early (<1 month after surgery) 18F-FDG PET/CTscans
for suspected FRI are no longer performed, diagnostic accuracy
can be expected to improve, in this study exclusion of such early
scans led to an increase in accuracy from 0.83 to 0.86.
The strengths of the current study are the large cohort size,
and the fact that a robust, standardized and repeatable scan
assessment was performed by two independent nuclear med-
icine physicians (one from each hospital) who were blinded to
the reference standard. We also used strict reference standard
criteria to determine whether FRI was present or not, based on
the recently published FRI consensus definition [4]. Finally,
the addition of SUV measurements and SUVanalysis provid-
ed additional insight into its merits and its performance com-
pared to standard qualitative assessments.
The limitations of the current study include its retrospective
design, with the associated risks of selection- and differential
misclassification bias. Patients were recruited in two different
teaching hospitals, thus there may have been differences in the
diagnostic work-up and treatment of FRI, as each hospital has
its own standard of care. Also, in some patients, FRI had
already been diagnosed and the 18F-FDG PET/CT scans were
used for treatment follow-up. This mainly occurred at the
beginning of the study period; since then, stricter protocols
have been adopted, which aim to standardize both 18F-FDG
PET/CT indications and microbiological culture acquisition
and treatment regimens. Finally, it is important to remember
that the combined assessment by two nuclear medicine spe-
cialists might have led to a higher diagnostic accuracy than
can be obtained in the normal clinical situation, in which only
one nuclear medicine physician reviews a scan. Further pro-
spective studies to compare different imaging modalities for
diagnosing FRI are warranted.
Conclusion
The results of the study can be summarized as follows:
1. Qualitative assessment of 18F-FDG PET/CT scans has
good accuracy (0.83) for diagnosing FRI, with an excel-
lent NPVof 0.91.
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2. SUVmeasurements provide additional diagnostic accura-
cy when added to qualitative assessment of 18F-FDG
PET/CT scans.
3. 18F-FDG PET/CT should not be performed for diagnosis
within a month of surgery.
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